The News Feed
Pharmaceuticals
Antibiotic Resistance Remains Prevalent in Ocular Staphylococcal Infections
Newest ARMOR study data helps inform clinicians when choosing a therapy to pursue in affected patients.
May 11, 2022
Hearing Loss a Possible Complication of Thyroid Eye Disease Drug
A small case series of teprotumumab-treated patients experienced auditory changes and other otologic symptoms.
March 8, 2022
Teprotumumab Promising as Treatment For Proptosis, Diplopia
Compared with placebo and methylprednisolone, the drug was associated with greater symptomatic improvement.
February 25, 2022
Oral CAIs More Safe Than Many Believe
The risk of adverse events was comparable to that of topical formulations, study finds.
February 1, 2022
First Presbyopia Eye Drop Approved
The pilocarpine agent improves near and intermediate acuity, according to manufacturer Allergan.
October 29, 2021
TNS Safe Treatment for Ocular Pain
Study suggests three- to six-month use of a trigeminal neurostimulator decreased eye pain, light and wind sensitivity, and burning sensations.
June 1, 2021
2021 ARMOR Results Find Staph Resistance Still Problematic
However, S. aureus had a significant decrease in methicillin resistance.
May 4, 2021
Economic Burden Worsens for Glaucoma Patients
Studies found additional IOP-lowering drops led to higher costs with only short-term benefits and observed a spike in brand name med prices.
March 24, 2021
Atropine Penetration Minimally Affected by Preservatives
Stability and safety of the drug are better predictors of successful outcomes.
February 16, 2021
Glaucoma Patients More Likely to Respond to Steroids
However, longer axial length and a heavier medication burden may decrease the effectiveness of therapy post-op.
February 9, 2021
LOAD MORE
Current News
Most Popular
Inner Nuclear Layer Thickness Aids in Glaucoma Progression
May 16, 2022
Posterior Scleral Strain May Help Identify Myopic Eye Susceptibility
May 16, 2022
Glaucoma Affects Refractive Outcomes
May 16, 2022
East Asian Eyes Develop More DR Lesions
May 13, 2022
Rapid Macular Thinning an Early Sign of HCQ Toxicity
May 13, 2022
×
Full Image